Vancouver, British Columbia – TheNewswire – September 11, 2020 – Blackhawk Growth Corp. (CSE:BLR) (CNSX:BLR.CN) (the “Corporation” or “Blackhawk“) announces that despite inquiries made to Emergence Technology Pty. Ltd. (“Emergence“) it has been unable to verify the nature of statements made by Innovita (Tangshan) Biological Technology Co. Ltd. (“Innovita“) surrounding authorization for the distribution of the 2019-nCoV Ab Test Kit (Colloidal Gold) in the United States.
As a result of uncertainty surrounding rights held by the Corporation, it has elected to suspend the distribution of the 2019-nCoV Ab Test Kit (Colloidal Gold) in all jurisdictions. The Company will notify shareholders in the event it is contacted by Innovita or receives further information in respect of the distribution of the 2019-nCoV Ab Test Kit (Colloidal Gold) in the United States.
Readers are encouraged to review the Company’s news release of June 25, 2020 for further information concerning its relationship with Emergence and Innovita.
For further information please contact:
Frederick Pels, Chief Executive Officer
Cautionary Note Regarding Forward-Looking Statement
All statements in this press release, other than statements of historical fact, are “forward-looking information” with respect to the Corporation within the meaning of applicable securities laws, including with respect to the status of its relationship with Innovita. The Corporation provides forward-looking statements for the purpose of conveying information about current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. These risks and uncertainties include but are not limited those identified and reported in the Corporation’s public filings under the Corporation’s SEDAR profile at www.sedar.com. Although the Corporation has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. The Corporation disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law.